Trial
NCT03905889
A Study of Abemaciclib in Combination With Sunitinib in Metastatic Renal Cell Carcinoma
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Brown University
Collaborators
Eli Lilly and Company
Condition
Renal Cell Carcinoma Metastatic
Intervention
Abemaciclib
Why stopped
Funding withdrawn
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-06-25